Medicament Delivery Device Patent Application
Summary
The USPTO has published a new patent application, US20260083914A1, related to a medicament delivery device and its subassembly. The application was filed on August 29, 2023, by inventors Daniel Säll, Tai-Fu Wang, and Chun-Hsien Huang.
What changed
The United States Patent and Trademark Office (USPTO) has published patent application US20260083914A1, detailing a medicament delivery device, specifically a subassembly for devices like autoinjectors. The application was filed on August 29, 2023, by inventors Daniel Säll, Tai-Fu Wang, and Chun-Hsien Huang, and includes various CPC classifications related to drug delivery mechanisms.
This publication represents a new patent application and does not impose immediate regulatory obligations. However, it is relevant for companies in the pharmaceutical and medical device sectors involved in the development or manufacturing of drug delivery systems, as it may indicate future technological advancements or potential intellectual property considerations.
Source document (simplified)
A medicament delivery device and a subassembly of a medicament delivery device
Application US20260083914A1 Kind: A1 Mar 26, 2026
Inventors
Daniel Säll, Tai-Fu Wang, Chun-Hsien Huang
Abstract
The present disclosure generally relates to medicament delivery devices such as autoinjectors, and particularly concerns a subassembly of a medicament delivery device.
CPC Classifications
A61M 5/20 A61M 5/31566 A61M 5/31586 A61M 5/3202 A61M 2005/2026 A61M 2205/332 A61M 2205/44 A61M 2205/502 A61M 2205/581
Filing Date
2023-08-29
Application No.
19110476
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Medical Devices (A61M) publishes new changes.